Bausch Health Q2 FY26 GAAP net income rises 74% to $258 million; revenue increases 13% to $2.85 billion - BHC News | RalliesBausch Health Q2 FY26 GAAP net income rises 74% to $258 million; revenue increases 13% to $2.85 billion
B
BHC• Q2 2026 results and guidance
- Bausch Health posted Q2 2026 GAAP net income attributable to shareholders of USD 258 million, lifting diluted GAAP EPS to USD 0.68.
- Revenue rose 13% from a year earlier to USD 2.85 billion; consolidated operating income climbed to USD 740 million.
- Consolidated adjusted EBITDA attributable to shareholders (non-GAAP) increased 28% to USD 1.08 billion.
- Management cited a thirteenth straight quarter of year-over-year revenue and adjusted EBITDA growth excluding Bausch + Lomb, with net debt reduced.
- 2026 revenue guidance increased to USD 10.79 billion–USD 11.04 billion; adjusted EBITDA (non-GAAP) lifted to USD 4.05 billion–USD 4.18 billion.
